Connects patients seeking medical cannabis evaluations with licensed physicians through an online telemedicine platform.
10-K for FY2025, filed Mar 27, 2026The Company currently conducts its principal operations through its majority-owned subsidiary PrestoCorp, Inc., doing business as…View ↗
The Company provides the technology platform and administrative support that facilitate telemedicine consultations between patients and…View ↗
The Company operates a technology-enabled telemedicine platform that facilitates medical cannabis evaluations conducted by licensed…View ↗
Patients pay for each telehealth visit through the online platform. The initial payment covers a one-time referral to a physician, and patients pay again for any additional consultations.
10-K for FY2025, filed Mar 27, 2026The telehealth division generates revenue based on a per telehealth visit for clients looking to obtain a permit to use marijuana for…View ↗
$738.9K
10-K for FY2025, filed Mar 27, 2026
$738.9K ↗
Patients schedule consultations through the PrestoDoctor platform and are connected with licensed physicians for medical cannabis evaluations.
10-K for FY2025, filed Mar 27, 2026
No. It lost $10M in FY2025.
10-K for FY2025, filed Mar 27, 2026
Fewer planned product businesses
The older report described plans to develop and sell branded cannabis and CBD products alongside telemedicine. The latest report describes telemedicine consultations as the principal operating business and says digital-asset initiatives are exploratory.
10-K for FY2022, filed Apr 14, 2022 10-K for FY2025, filed Mar 27, 2026
Loading...